Rubric Capital Management (New York)’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-877,161
Closed -$4.4M 104
2022
Q4
$4.4M Hold
877,161
0.19% 73
2022
Q3
$11.5M Buy
877,161
+79,573
+10% +$1.04M 0.58% 43
2022
Q2
$10.2M Buy
+797,588
New +$10.2M 0.54% 43